Equity Brief · Healthcare2026-10-27
RJF.MC·Healthcare

Laboratorio Reig Jofre, S.A.

I · AI Analysis

The brief

Reig Jofre manufactures pharmaceutical products including antibiotics and injectable drugs, specialty pharmacy items for skin and joint health, nutritional supplements under the Forté Pharma brand, and provides contract manufacturing services to other pharmaceutical companies [Yahoo Finance].

Laboratorio Reig Jofre is a Spanish pharmaceutical company that manufactures antibiotics, injectables, specialty skincare products, nutritional supplements, and provides contract manufacturing services [Yahoo Finance]. The company faces significant financial stress: it burned EUR 16.8M in free cash flow over the trailing twelve months, carries debt at 4.3 times EBITDA, and scores just 3.3/10 on financial health [Sentinellis calculation]. With a market cap of EUR 211.8M and trailing-twelve-month revenue of EUR 337.7M through 30 June 2026, the company is small and thinly traded [Yahoo Finance].

The company is under material financial stress with negative free cash flow, high leverage, and weak profitability.

The brief AI analysisConfidence 5/10

Sentinellis health

Significant risks

3.3/10

7.5+ strong · 4.5–7.5 moderate · under 4.5 weak

Profitability

14% of score0.0/10
Net margin+2.1%· need ≥ 12.4%, the lower third of pharma in our libraryGross margin+59.4%· need ≥ 70.8%, the lower third of pharma in our library

Returns on capital

14% of score0.0/10
ROIC+3.3%· need > 10%Return on equity+3.1%· need > 12%

Growth & momentum

19% of score5.0/10
Revenue growth+1.1%· need ≥ 1.2%, the lower third of pharma in our libraryOperating margin trend+4.6pp YoY

Balance sheet

29% of score8.3/10
Current ratio1.5xNet debt / EBITDA4.3x· need < 3.5xInterest coverage9.9xDebt / equity0.54

Cash generation

14% of score0.0/10
Free cash flowEUR -16.8M· need positiveCash vs reported profitEUR 1.5M vs EUR 5.0M· need OCF > net income

Value creation

10% of score0.0/10
ROIC vs cost of capital-2.5pp· need ROIC above WACC

Sentinellis calculation from the published statements — not a score reported by any data source. Each category is scored on the checks that had data; missing inputs are excluded rather than counted as failures.

Market capitalisation

EUR 211.8M

Revenue (TTM)

EUR 337.7M

Explainers

How we read these numbers

Plain-English guides · no account needed

Premium · Free with any account

The company burned EUR 16.8M in free cash flow over the trailing twelve months, meaning it consumed more cash than it generated from operations after capital expenditures [Sentinellis calculation].

1 of 6 risks in this report

Risks

6

Opportunities

4

Red flags

5

Leadership

3

14 more findings in the full report — free with any account.

Unlock the full Laboratorio Reig Jofre, S.A. analysis

Create a free account to access the complete AI-generated report with inline citations.

  • 6 risks, 4 opportunities and 5 red flags — each with its source
  • 100+ financial metrics with charts and benchmarks
  • Full news summaries with source links
  • Executive team and compensation details
  • PDF export for offline use
Unlock all 15 findings3 free reports · No credit card

III · Related

You might also read

Same sector · Healthcare — or comparable health

Want this for your watchlist?

Read three companies free. No card.

Get 3 free reports

Produced 27 Oct 2026, 10:57 UTC

Figures come from company filings and market data. The Sentinellis health score and the wording attached to it are our interpretation of those figures, not numbers the company reported.

Not investment advice and not a recommendation to buy or sell. Sentinellis holds no positions in the companies it covers, takes no payment from issuers, and has no broker referral arrangements.

How every figure and score is calculated